PAPAYA is a Percutaneous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Allergy Laboratories, Inc.. The primary component is Papaya.
| Product ID | 54575-426_dbe7bebd-e445-4e59-8302-e706b795fbde |
| NDC | 54575-426 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PAPAYA |
| Generic Name | Papaya |
| Dosage Form | Injection, Solution |
| Route of Administration | PERCUTANEOUS; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Allergy Laboratories, Inc. |
| Substance Name | PAPAYA |
| Active Ingredient Strength | 1 g/20mL |
| Pharm Classes | Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Fruit Proteins [EXT] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| PAPAYA | 1 g/20mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-1598 | Papaya | Papaya |
| 36987-1599 | Papaya | Papaya |
| 36987-1600 | Papaya | Papaya |
| 36987-1601 | Papaya | Papaya |
| 54575-426 | PAPAYA | papaya |